Alzheimer’s affects millions, but early diagnosis is often costly and invasive, requiring expensive brain scans or spinal fluid tests. To solve this, scientists at WashU developed a simple blood test that measures the p-tau217 protein. This test acts as a "biological clock," predicting the start of symptoms within three to four years. This breakthrough benefits patients by allowing for early prevention plans and speeds up clinical trials for life-saving treatments.
